Faculty Disclosures
| Albert Lo, MD, PhD |
No disclosure on file
|
| Mindy A. Aisen, MD |
No disclosure on file
|
| Scott J. Stevens, MD |
No disclosure on file
|
| Marcello Romano, MD |
No disclosure on file
|
| Christopher T. Whitlow, MD |
Dr. Whitlow has nothing to disclose. |
| Johna Register-Mihalik, PhD |
No disclosure on file
|
| Joshua D. VanDerWerf, MD |
No disclosure on file
|
| Cullen M. O'Gorman, MBBS |
Dr. O'Gorman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Australia Pty. An immediate family member of Dr. O'Gorman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck Australia. An immediate family member of Dr. O'Gorman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka. |
| Michael W. Ruff, MD |
Dr. Ruff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Radmetrix. Dr. Ruff has received intellectual property interests from a discovery or technology relating to health care. |
| Lindsy N. Williams, MD |
No disclosure on file
|
| Gerard A. Gioia, MD |
Dr. Gioia has received personal compensation in the range of $0-$499 for serving as a Consultant for Global Pharma Consultancy. Dr. Gioia has received publishing royalties from a publication relating to health care. |
| Erik P. Pioro, MD, DPhil, FAAN |
Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc.. |
| J. R. Singleton, MD |
Dr. Singleton has received research support from NIH. |
| Richard Leigh, MD |
The institution of Dr. Leigh has received research support from National Institutes of Health. The institution of Dr. Leigh has received research support from American Heart Association. Dr. Leigh has received intellectual property interests from a discovery or technology relating to health care. |
|
No disclosure on file
|
| Meeryo Choe, MD, FAAN |
Dr. Choe has received personal compensation for serving as an employee of Harvard-Westlake School. Dr. Choe has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Cases. The institution of Dr. Choe has received research support from NIH. Dr. Choe has a non-compensated relationship as a Board of Directors with NABIS that is relevant to AAN interests or activities. Dr. Choe has a non-compensated relationship as a Consultant with USA Swimming Concussion Task Force that is relevant to AAN interests or activities. |
| Sean Hwang, MD |
Dr. Hwang has nothing to disclose. |
| Shrikant Mishra, MD |
Dr. Mishra has nothing to disclose. |
| Andrea Formella, PharmD, BCPP |
Dr. Formella has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc. Dr. Formella has stock in Supernus Pharmaceuticals, Inc.. |
| Soma Sahai-Srivastava, MD |
No disclosure on file
|
| Clotilde Balucani, MD, PhD |
Dr. Balucani has nothing to disclose. |
| Paul Shin |
No disclosure on file
|
| Imama A. Naqvi, MD |
Dr. Naqvi has nothing to disclose. |
| sidrah mahmud, MD |
No disclosure on file
|
| Christopher Giza, MD, FAAN |
Dr. Giza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Network Speakers Bureau. Dr. Giza has stock in Highmark Interactive. The institution of Dr. Giza has received research support from UCLA: Brain Injury Research Center, Steve Tisch BrainSPORT Program, Easton Clinic for Brain Health. Dr. Giza has received publishing royalties from a publication relating to health care. Dr. Giza has a non-compensated relationship as a Advisory Board with Major League Soccer that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Advisory Board with National Basketball Association that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Consultant with United States Soccer Federation that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Co-founder & Advisor with Symptomwise that is relevant to AAN interests or activities. |
| Derek Cheng, MD |
No disclosure on file
|
| Kevin Guskiewicz, PhD, ATC |
No disclosure on file
|
| Fred Rivara |
No disclosure on file
|
| Sandeep Singh, MD |
Dr. Singh has nothing to disclose. |
| Shaweta Khosa |
Ms. Khosa has nothing to disclose. |
| Brigida Fierro |
No disclosure on file
|
| Briana P. Meyer |
No disclosure on file
|
| David Popoli |
No disclosure on file
|
| Kristy Arbogast |
The institution of Kristy Arbogast has received research support from NIH. The institution of Kristy Arbogast has received research support from Pennsylvania Department of Health. The institution of Kristy Arbogast has received research support from Football Research Inc. |
| Filippo Brighina, MD |
Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. |
| Philip Rosenbaum |
Mr. Rosenbaum has received research support from Region IV Training Center. |
| Constance Johnson, MA |
No disclosure on file
|
| Christina Master, MD, FAAP, CAQSM |
The institution of Dr. Master has received research support from NIH. The institution of Dr. Master has received research support from DoD. The institution of Dr. Master has received research support from AMSSM. The institution of Dr. Master has received research support from PA Department of Health. Dr. Master has received intellectual property interests from a discovery or technology relating to health care. Dr. Master has received intellectual property interests from a discovery or technology relating to health care. Dr. Master has received intellectual property interests from a discovery or technology relating to health care. |
| Christopher Miles |
No disclosure on file
|
| David Do, MD |
Dr. Do has nothing to disclose. |
| Emi Hitomi |
No disclosure on file
|
| Katherine Schwartz, DO |
No disclosure on file
|
| Benjamin R. Brooks, MD, FAAN |
Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with 好色先生 that is relevant to AAN interests or activities. |
| Andrea Loggini, MD, MBA |
Dr. Loggini has nothing to disclose. |